Aardvark Therapeutics Inc (AARD) Stock Price, Quote, News & History

AARDNASDAQ
$3.84
-0.06-1.54%
At close: Jun 15, 5:00 PM EST
$3.78
-0.06-1.56%
After Hours: 5:38 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-61.65M
Investing Cash Flow (TTM)
97.21M
Financing Cash Flow (TTM)
378.00K
Free Cash Flow (TTM)
-61.75M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
35.93M

Analyst Trends and Forecast

1
Dec 25
2
Feb
3
2
Mar
1
1
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$5.78M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.98
Earnings Yield % (TTM)
-82.31%
Earnings Yield % (FWD)
-93.59%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.99

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$62.44M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.90
Close
$3.84
Volume / Avg.
206.54K / 195.21K
Day Range
$3.81 - $4.10
52 Wk Range
3.35 - 17.94
Market Cap
$82.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
6.85%
Days to Cover
5.55

About

Sector
Health Care
Industry
Pharmaceuticals
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Aardvark Therapeutics (AARD) stock?

A

You can purchase shares of Aardvark Therapeutics (NASDAQ:AARD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aardvark Therapeutics (AARD) competitors?

A

There are no as such competitors for Aardvark Therapeutics.

Q

What is the forecast, or price target, for Aardvark Therapeutics (AARD) stock?

A

Aardvark Therapeutics has a consensus price target of $18.88.

Q

What is the current price for Aardvark Therapeutics (AARD)?

A

The stock price for Aardvark Therapeutics (NASDAQ: AARD) is $3.78 last updated June 15, 2026 at 5:38 PM EDT.

Q

Does Aardvark Therapeutics (AARD) pay a dividend?

A

There are no upcoming dividends for Aardvark Therapeutics.

Q

When is Aardvark Therapeutics (NASDAQ:AARD) reporting earnings?

A

Aardvark Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aardvark Therapeutics (AARD) going to split?

A

There is no upcoming split for Aardvark Therapeutics.

Q

What sector and industry does Aardvark Therapeutics (AARD) operate in?

A

Aardvark Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.